Doctor Tomoko Ichiki
Mayo Clinic, Rochester (United States of America)
Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support
Event: ESC Congress 2018
Topic: Pharmacotherapy
Session: Chronic heart failure – Treatment
Circulating corin in the general community: link to gender and metabolic dysfunction
Event: ESC Congress 2018
Topic: Biomarkers
Session: Risk factors and prevention
Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure
Event: ESC Congress 2016
Topic: Pharmacologic therapy
Session: Drug therapy of heart failure
ESC 365 is supported by
